“The longest-lasting benzodiazepine is not a single drug but a small group. Diazepam (Valium), chlordiazepoxide (Librium), clorazepate, and flurazepam all have effective half-lives of roughly 100 hours, and in some people diazepam and chlordiazepoxide take as long as 200 hours to clear [1][2].
At the other end, triazolam is gone in about two hours [2]. That spread, from hours to more than a week, is the most useful way to sort these commonly prescribed medications. It is also one of the first things a benzodiazepine treatment program in Minnesota asks about, because how long a drug stays active shapes how dependence develops and what withdrawal looks like. This chapter covers which drugs fall where and why duration matters.”
What “Longest Lasting” Actually Means
Every benzodiazepine works the same way. It acts as a positive allosteric modulator at GABA receptors, amplifying gamma-aminobutyric acid, the brain’s primary inhibitory neurotransmitter and the chemical the central nervous system uses to slow nerve signals, which is why the whole class can treat anxiety, relax muscles, and bring on sleep. What separates one drug from another is timing, and the shared mechanism behind all of them is covered in our guide to what benzodiazepines are and how they work.
Half-life is the time it takes for the amount of a drug in the body, or its plasma concentration, to fall by half during elimination. A longer half-life means the drug can persist for days and may accumulate with repeated dosing; a shorter half-life means concentrations fall more quickly. Half-life is not the same as onset or the exact length of the noticeable effect: diazepam can act quickly while still remaining in the body for a long time.
Several long-acting drugs also form active metabolites that continue contributing to their pharmacologic effects after much of the parent drug has been eliminated. Diazepam forms desmethyldiazepam, temazepam, and oxazepam, which helps explain its prolonged overall elimination [3]. Duration is also a separate question from potency, which is the subject of the chapter on the strongest benzodiazepine.
Long Acting vs. Short Acting Benzodiazepines
Clinicians sort the class into two broad groups by half-life, and some references add an intermediate group between them. The boundaries are approximate, because individual metabolism varies.
Long-Acting Benzodiazepines
Long-acting benzos have half-lives measured in days. Chlordiazepoxide and diazepam run 36 to 200 hours, clonazepam (Klonopin) 20 to 60 hours [1], and clorazepate and flurazepam sit alongside diazepam at around 100 hours [2]. Clonazepam is prescribed for panic disorder and seizure disorders, clorazepate works through its active metabolite and is used for anxiety and seizures, and flurazepam is a sleeping pill whose long half-life often leaves daytime sedation.
This is how long-acting benzodiazepines work in practice: each dose builds on the one before it, blood levels stay steady, the drop between doses is gentle, and the drug may not need to be taken as often. That steadiness is why diazepam and chlordiazepoxide are standard choices to treat alcohol withdrawal, where a smooth decline protects against the seizures of alcohol withdrawal syndrome, and why long-acting drugs are also used for seizure disorders, muscle spasms, and anxiety disorders that need round-the-clock coverage. Some, such as clonazepam and chlordiazepoxide, also take longer to show effects; diazepam is the exception, with its fast onset. The difference between a drug wearing off and a drug being detectable is explained in how long each benzodiazepine stays in your system.
Short Acting Benzodiazepines
Shorter acting agents have concentrations that fall more quickly, although they are not necessarily completely cleared within a day. Alprazolam (Xanax) is listed at about 12 to 15 hours, lorazepam (Ativan) 10 to 20 hours, oxazepam 6 to 20 hours, and temazepam 5 to 15 hours [1]. Triazolam is among the shortest, with an elimination half life of roughly 1.5 to 5.5 hours [2]. Depending on the drug, these medications may be used for insomnia, panic disorder, acute anxiety, or other indications.
Lorazepam is also a standard medication for acute seizures when given intravenously. Lorazepam is unusual in being metabolized mainly through glucuronidation rather than the liver’s CYP enzyme system, which is one reason it may be preferred over some other benzodiazepines in patients with significant liver disease [3]. Where it sits on the timeline is covered in our chapter on lorazepam duration.
Why Duration Matters for Benzodiazepine Dependence
Duration does not decide whether dependence happens. The FDA’s boxed warning for the entire class states that physical dependence can develop after steady use for days to weeks even at prescribed doses [5]. Risk depends on several factors, including dose, frequency, duration of treatment, and the specific drug. Half-life has an especially important effect on withdrawal: shorter-acting drugs generally produce falling concentrations sooner after a dose, while longer-acting drugs can delay the onset of symptoms. Alprazolam is a notable example because its short half-life, rapid onset, and lack of active metabolites are associated with relatively rapid physical dependence and more difficult withdrawal. Dependence can develop with both short- and long-acting benzodiazepines.
Short Half-Life: Withdrawal Between Doses
When concentrations of a shorter-acting drug fall quickly, some people experience symptoms before the next scheduled dose. Anxiety may return between doses, sleep may deteriorate overnight, or other symptoms may appear in a pattern that follows the dosing schedule. This is sometimes called interdose withdrawal. Shorter half-life, lack of active metabolites, daily use, higher doses, and longer treatment are among the factors associated with more severe benzodiazepine withdrawal.
Alprazolam is particularly difficult for some people to taper because it combines a relatively short half-life with rapid onset and no clinically important long-lived active metabolite. Stopping a short-acting drug can bring withdrawal on sooner, and the risks of that process, including seizures, are laid out in the chapter on why benzodiazepine withdrawal can become a medical emergency
Long Half Life: Accumulation and Delayed Withdrawal
Because concentrations fall slowly, long-acting benzodiazepines and their active metabolites can accumulate with repeated use. This matters particularly in older adults, who may be more sensitive to benzodiazepines and may clear some long-acting agents more slowly. The American Geriatrics Society’s Beers Criteria recommend avoiding benzodiazepines in most older adults because the class increases the risk of cognitive impairment, delirium, falls, fractures, and motor vehicle crashes. Studies have associated benzodiazepine use with substantially higher hip-fracture risk in older adults, although the size of that risk varies with the drug, dose, frequency, and characteristics of the person taking it [4].
Driving impairment has also been compared with the crash risk seen around a blood alcohol concentration of 0.05 to 0.08 percent [4]. Memory problems may be mistaken for aging or other medical conditions, and whether long-term exposure is associated with dementia is examined in our chapter on Xanax and dementia risk. When a long-acting benzodiazepine is stopped, withdrawal symptoms may take longer to appear than they do with a short-acting drug and can continue for an extended period. Long half-life may reduce abrupt concentration changes, but it does not guarantee mild withdrawal.
Long-Term Benzodiazepine Use: What Changes Over Months
The duration question has a second meaning: not how long a dose lasts, but how long a person has been taking benzodiazepines. A 2013 review in American Family Physician argued against routine continuous use beyond about one month for anxiety and insomnia because dependence and withdrawal can develop and benefits for problems such as insomnia may diminish with ongoing treatment [4].
More recent guidelines likewise generally recommend limiting benzodiazepine treatment to a few weeks when possible, while recognizing that longer use can be appropriate for selected conditions and patients. When benzodiazepines are used for sleep problems, their effectiveness can diminish after several weeks [4]. Tolerance means that the same dose produces less of an effect than it once did, which can contribute to dose escalation and long-term benzodiazepine use. Whether any one drug in the class is a safer long-term choice is the question taken up in the safest benzodiazepine chapter.
The same review estimated that about 4 million people in the United States take a benzodiazepine daily and that many meet the criteria for dependence [4]. Long-term benzodiazepine use raises the risk of addiction and is also linked to cognitive decline that, in one analysis, had not resolved three months after people stopped [4]. Benzodiazepines are Schedule IV controlled substances.
Taking them for non-medical purposes or at high doses, or combining them with other drugs or other substances, especially alcohol and opioids, sharply raises the risk of overdose, since all of them are central nervous system depressants with the same toxic effects when stacked. That is not a reason to stop on your own: the FDA warns that stopping abruptly can be life-threatening [5], and the safer path is a supervised taper, which for the most widely prescribed short-acting drug is described in how to wean off lorazepam.
Frequently Asked Questions About Long-Acting Benzodiazepines
Is Clonazepam or Diazepam Longer Acting?
Diazepam. Clonazepam has a half-life of roughly 20 to 60 hours, while diazepam and its active metabolites can take 36 to 200 hours to clear, placing it among the longest-lasting benzodiazepines [1]. Both are long-acting; the difference shows up mainly in how soon withdrawal begins after the last dose.
Is Lorazepam Short Acting or Long Acting?
Lorazepam is short-acting, with a half-life of about 10 to 20 hours and no active metabolites [1][3]. That makes it useful for acute anxiety and for people with liver disease, and it means withdrawal between doses is more noticeable than with a long-acting drug such as diazepam.
Is Xanax a Short-Acting Benzo?
Yes. Alprazolam has a relatively short half-life, averaging around 11 to 15 hours in most references, and it has no long-lived active metabolites [1][3]. Its noticeable effects therefore wear off much sooner than those of drugs such as diazepam, although the medication is not completely eliminated within one day. Alprazolam also combines a rapid onset with relatively rapid elimination, which helps explain why some people experience pronounced rebound or between-dose symptoms and why physical dependence can develop relatively quickly with regular use.
Can Benzodiazepine Tolerance Be Reversed?
Tolerance can decrease after benzodiazepine use is reduced or stopped, but it does not disappear as soon as the drug leaves the bloodstream. The nervous system adaptations that develop during regular use can take longer to reverse, and that process overlaps with physical dependence and withdrawal.
For someone who has become physically dependent, reducing benzodiazepines safely usually means an individualized taper rather than abruptly stopping. The pace depends on factors including the drug and dose, how frequently and how long it has been taken, other health conditions, previous withdrawal experiences, and how the person responds to each dose reduction.
Finding Professional Treatment in Minnesota
If a benzodiazepine has become hard to stop, whether a short-acting drug taken several times a day or a long-acting one that has quietly accumulated, the way off is the same. It is a supervised taper worked out with a healthcare provider, plus support for the anxiety or sleep problems underneath. Northwoods Haven’s intensive outpatient program coordinates with prescribers on tapers and treats the conditions the medication was managing, on a schedule built around work and family. Reach out for a confidential conversation.
Sources
- Mind, “Comparing benzodiazepines,” Sleeping pills and minor tranquillizers, published April 2021. https://www.mind.org.uk/information-support/drugs-and-treatments/sleeping-pills-and-minor-tranquillisers/comparing-benzodiazepines/
- Medscape, “Benzodiazepine Equivalency Chart,” eMedicine Drugs and Diseases reference. https://emedicine.medscape.com/article/2172250-overview (accessed September 23, 2026).
- Bounds CG, Patel P, “Benzodiazepines,” StatPearls, National Library of Medicine, last updated January 30, 2024. https://www.ncbi.nlm.nih.gov/books/NBK470159/
- Johnson B, Streltzer J, “Risks Associated with Long-Term Benzodiazepine Use,” American Family Physician, August 15, 2013;88(4):224-226. https://www.aafp.org/afp/2013/0815/p224
- U.S. Food and Drug Administration, “FDA requiring Boxed Warning updated to improve safe use of benzodiazepine drug class,” Drug Safety Communication, September 23, 2020. https://www.fda.gov/drugs/drug-safety-and-availability/fda-requiring-boxed-warning-updated-improve-safe-use-benzodiazepine-drug-class
